Search Results
Apr 30, 2026, 16:48 ET LG&E and KU collaborate with X-energy to explore nuclear energy
Commonwealth to help ensure we maintain and build upon our strong competitive energy advantage with reliable and affordable power," said John R. Crockett III, President for LG&E and KU. "On the heels of the Nuclear Reactor Site Readiness Pilot Program being signed into law this month, we're proud to work
More news about: LG&E and KU
Apr 30, 2026, 16:30 ET QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2026 RESULTS
ResultsThe Company's first quarter of 2026 operating performance for each of its three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific, is further described below.
More news about: Quaker Chemical Corporation
Apr 30, 2026, 16:30 ET Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2026 and Cash Dividend
III. Condensed Consolidated Balance Sheets(In thousands, unaudited)
More news about: Select Medical Holdings Corporation
Apr 30, 2026, 16:15 ET CNO Financial Group Reports First Quarter 2026 Results
net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable, investment borrowings and financing arrangements; (iv) expenses related to the funding agreement-backed notes ("FABN")
More news about: CNO Financial Group
Apr 30, 2026, 16:15 ET MATTHEWS INTERNATIONAL REPORTS RESULTS FOR FISCAL 2026 SECOND QUARTER
performance using the same tools that management uses to budget, forecast, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating the Company's results. The Company's calculations of its non-GAAP
More news about: Matthews International Corporation
Apr 30, 2026, 16:10 ET NaaS Technology Inc. Announces Results of Extraordinary General Meeting on April 29, 2026
365,300,000,000 Class A ordinary shares of a par value of US$0.000001 each, (ii) 300,000,000 Class B ordinary shares of a par value of US$0.000001 each, (iii) 1,400,000,000 Class C ordinary shares of a par value of US$0.000001 each, (iv) 16,000,000 Class D ordinary shares of a par value of US$0.000001 each,
More news about: NaaS Technology Inc.
Apr 30, 2026, 16:05 ET GRAND CANYON EDUCATION, INC. REPORTS FIRST QUARTER 2026 RESULTS
the occurrence of any event, change or other circumstance that could give rise to the termination of any of the key university partner agreements; (iii) our ability to properly manage risks and challenges associated with strategic initiatives, including potential acquisitions or divestitures of, or investments
More news about: Grand Canyon Education, Inc.
Apr 30, 2026, 16:05 ET Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
growth in the markets we serve, including the proteomics market; (ii) the volume, timing and mix of customer orders among our products and services; (iii) our ability to adjust our operating expenses to align with our revenue expectations; (iv) our ability to successfully integrate SomaLogic, Inc. and
More news about: Illumina, Inc.
Apr 30, 2026, 16:01 ET ALLEGIANT TRAVEL COMPANY FIRST QUARTER 2026 FINANCIAL RESULTS
incurred primarily as the result of hurricanes and other insured events at Sunseeker Resort, (ii) other charges related to the sale of Sunseeker, and (iii) the airline special charges listed in the table below. We also present adjusted consolidated interest expense, adjusted consolidated income before income
More news about: Allegiant Travel Company
Apr 30, 2026, 16:00 ET FiEE, Inc. Announces First Quarter 2026 Unaudited Financial Results
(i) the future financial position and performance of the Company, (ii) our ability to successfully implement our strategic business transformation, (iii) our long-term growth objectives and opportunities, (iv) our commitment to investing in R&D to expand our service offerings, enhance customer experience,
More news about: FiEE, Inc.
Apr 30, 2026, 15:28 ET SCENTRE GROUP ANNOUNCES CONSIDERATION FOR TENDER OFFER
reserves the right, subject to applicable law, to (i) waive any and all conditions to the Tender Offer, (ii) extend or terminate the Tender Offer, or (iii) otherwise amend the Tender Offer in any respect.Dealer Managers and Tender and Information AgentThe Offeror has appointed Merrill
More news about: Scentre Group
Apr 30, 2026, 14:29 ET Norgine annuncia l'autorizzazione all'immissione in commercio da parte della Commissione europea per XOLREMDI ® (mavorixafor), la prima terapia autorizzata per i pazienti con sindrome WHIM nell'Unione Europea
possibile".L'autorizzazione all'immissione in commercio da parte della Commissione europea si basa sui risultati dello studio clinico pivotale di fase III WHIM, uno studio multicentrico globale, randomizzato, in doppio cieco, controllato con placebo, di 52 settimane che ha valutato l'efficacia e la sicurezza
More news about: Norgine B.V.
Apr 30, 2026, 12:45 ET SuperOrdinary to redefine its creator commerce ecosystem by inviting its creator community to become shareholders
of the Securities Act and will not be required to comply with specific disclosure requirements that apply to registration under the Securities Act; (iii) the United States Securities and Exchange Commission will not pass upon the merits of or give its approval to the securities, the terms of the offering,
More news about: SuperOrdinary
Apr 30, 2026, 12:38 ET Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
(GBM). GBM is the most aggressive and lethal form of primary brain cancer, and is an "orphan disease." The Company has completed a 331-patient Phase III trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval
More news about: Northwest Biotherapeutics, Inc.
Apr 30, 2026, 12:30 ET Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
(GBM). GBM is the most aggressive and lethal form of primary brain cancer, and is an "orphan disease." The Company has completed a 331-patient Phase III trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval
More news about: Northwest Biotherapeutics, Inc.
Apr 30, 2026, 12:16 ET Boyne Capital Closes Oversubscribed BCM Fund III at over $400 Million
pleased to announce the first and final closing of its third investment fund, BCM Fund III, LP ("BCM Fund III" or "Fund III"). Fund III was oversubscribed and closed at its hard cap with total limited partner commitments of $355 million,
More news about: Boyne Capital
Apr 30, 2026, 12:12 ET Shrub Oak International School Expands Innovative Program for DeafDisabled Students
support.Shrub Oak International School is accredited by:The National Independent Private Schools Association (NIPSA), Level III Therapeutic Certification, Academic Accreditation, with an Autism Endorsement;The Middle States Association Commission on Elementary and Secondary
More news about: Shrub Oak International School
Apr 30, 2026, 12:00 ET Reverence Capital Partners Closes More Than $2 Billion Recapitalization of Osaic
investment firm focused on three complementary strategies: (i) financial services-focused private equity, (ii) opportunistic, structured credit, and (iii) real estate solutions. Today, Reverence Capital manages in excess of $14 billion in AUM. Reverence focuses on thematic investing in leading global financial
More news about: Reverence Capital Partners
Apr 30, 2026, 11:42 ET The Camera Is the New Sensor: Why a Provisional Patent Filing in Hollywood Could Reshape How the Pentagon Buys Vision
issued claims of commercial value; (ii) technical, regulatory, and market risks associated with the development and commercialization of xCalibre™; (iii) the Company's ability to secure government contracts; (iv) competition; (v) dependence on key personnel; and (vi) general economic and defense-budget
More news about: Equity Insider
Apr 30, 2026, 10:55 ET HCLTech expands Cornerstone Partnership with MetLife Stadium, New York Jets and New York Giants as an Official AI Partner
the 1968 season, the team made history by becoming the first AFL franchise to win a world championship, defeating the Baltimore Colts in Super Bowl III—a victory widely credited with validating the AFL ahead of its 1970 merger with the NFL. Today, as one of the league's flagship franchises in the nation's
More news about: HCLTech
Apr 30, 2026, 10:38 ET El primer fármaco recombinante de toxina botulínica tipo A del mundo obtiene la autorización de comercialización en China: una revolución tecnológica impulsada por Claruvis Pharmaceutical
derivada del Clostridium botulinum, y ofrece una toxina de alta pureza y alta actividad específica.En un ensayo clínico multicéntrico de fase III, aleatorizado, doble ciego y controlado con placebo y fármaco activo, realizado en China, Retoxin® alcanzó todos los criterios de valoración
More news about: Claruvis Pharmaceutical
Apr 30, 2026, 09:50 ET CWH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Camping World Holdings (CWH) Investors of Securities Class Action Deadline on May 11, 2026
optimize profit using "data analytics;" (ii) the Company overstated the retail demand of consumers it was experiencing and/or reasonably expected; (iii) as a result, the Company would require "strict, corrective inventory management objectives," negatively impacting gross profit and margins; (iv) the
More news about: Faruqi & Faruqi, LLP
Apr 30, 2026, 09:41 ET ATTENTION NYSE: SES INVESTORS: Contact Berger Montague About an SES AI Corporation Class Action Lawsuit
circular counterparties; (ii) the Company faced operational constraints that undermined its ability to generate the revenues it had projected; and (iii) underlying demand for SES AI's products was deteriorating.On December 9, 2025, Wolfpack Research published a report alleging that SES AI had
More news about: Berger Montague
Apr 30, 2026, 09:38 ET ODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Oddity Tech (ODD) Investors of Securities Class Action Deadline on May 11, 2026
the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (iii) accordingly, Defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and
More news about: Faruqi & Faruqi, LLP
Apr 30, 2026, 09:26 ET PINS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Pinterest (PINS) Investors of Securities Class Action Deadline on May 29, 2026
reallocating resources to AI-focused roles and teams that drive AI adoption and execution, (ii) prioritizing AI powered products and capabilities, and (iii) accelerating the transformation of its sales and go-to-market approach."On this news, Pinterest's stock price fell $2.49 per share, or 9.61%,
More news about: Faruqi & Faruqi, LLP